Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	2016 - 2020
Period Ending	Oct '25 Oct 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Market Capitalization	196	216	113	35	44	113	Upgrade
Market Cap Growth	-76.34%	91.16%	221.19%	-19.99%	-61.12%	200.36%	Upgrade
Enterprise Value	8	-48	98	-19	-14	49	Upgrade
Last Close Price	2.64	3.19	4.02	2.47	3.09	7.98	Upgrade
PS Ratio	153.99	148.28	78.65	6.49	-	11.23	Upgrade
PB Ratio	0.74	0.74	1.50	0.64	0.72	1.68	Upgrade
P/TBV Ratio	0.91	0.90	147.82	0.64	0.72	1.68	Upgrade
EV/Sales Ratio	6.51	-	68.42	-	-	4.86	Upgrade
Debt / Equity Ratio	0.01	0.01	0.03	-	0.01	0.01	Upgrade
Asset Turnover	0.00	0.01	0.02	-	-	0.25	Upgrade
Inventory Turnover	-	-	-	-	-	6.07	Upgrade
Quick Ratio	14.77	12.53	0.67	14.47	25.38	36.58	Upgrade
Current Ratio	15.09	12.68	1.08	17.07	26.18	37.37	Upgrade
Return on Equity (ROE)	-31.47%	-42.82%	-57.70%	-	-9.79%	-9.26%	Upgrade
Return on Assets (ROA)	-15.32%	-19.02%	-32.81%	-	-5.95%	-5.43%	Upgrade
Return on Capital (ROIC)	-17.38%	-22.42%	-38.66%	-	-6.17%	-5.73%	Upgrade
Earnings Yield	-48.43%	-36.77%	-41.23%	-30.64%	-16.57%	-3.00%	Upgrade
FCF Yield	-58.55%	-33.72%	-33.68%	-30.42%	-18.17%	-2.85%	Upgrade
Buyback Yield / Dilution	-67.21%	-140.72%	-88.38%	-0.06%	-36.73%	-53.61%	Upgrade

Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q